1. LITT aids over half of drug-resistant epilepsy patients in achieving seizure freedom.
2. Median hospital stay post-LITT is 1.3 days.
3. 58.4% of patients achieved Engel class I outcomes after 2 years.
4. Most adverse events were mild to moderate.
5. Quality of life improved significantly, especially in seizure worry.
6. LITT offers comparable outcomes to open surgery.
7. No significant factors correlated with seizure outcomes.

Source: JAMA Neurology